A5049816480- Cardiac electrophysiology and arrhythmias
- Cardiac Arrhythmias and Treatments
- Cardiac pacing and defibrillation studies
- Atrial Fibrillation Management and Outcomes
- Cardiomyopathy and Myosin Studies
- Ion channel regulation and function
- Cardiovascular Function and Risk Factors
- Cardiac Imaging and Diagnostics
- Viral Infections and Immunology Research
- Heart rate and cardiovascular health
- Cardiovascular Effects of Exercise
- Heart Failure Treatment and Management
- ECG Monitoring and Analysis
- Antiplatelet Therapy and Cardiovascular Diseases
- Receptor Mechanisms and Signaling
- Cardiovascular Syncope and Autonomic Disorders
- Acute Myocardial Infarction Research
- Cardiovascular Disease and Adiposity
- Tissue Engineering and Regenerative Medicine
- Muscle Physiology and Disorders
- Nuclear Structure and Function
- Pulmonary Hypertension Research and Treatments
- Cardiac Fibrosis and Remodeling
- Genomics and Rare Diseases
- Cardiac Structural Anomalies and Repair
Arcispedale Sant'Anna
2016-2025
University of Ferrara
2018-2025
Luigi Sacco Hospital
2023
University Radiology
2023
St. Anna Hospital
2021
Angiologica (Italy)
2021
Ospedale Sant'Anna
2020
Maria Cecilia Hospital
2015-2019
Azienda Unità Sanitaria Locale di Ferrara
2017
Humanitas Gavazzeni
2017
Patients with SCAD and concomitant COPD are at high risk of cardiovascular adverse events, due to chronic inflammation, responsible endothelial dysfunction, oxidative stress heightened platelet reactivity (PR). The objective this randomised clinical trial was test if ticagrelor is superior clopidogrel in improving function patients stable coronary artery disease (SCAD) obstructive pulmonary (COPD). Forty-six undergoing percutaneous intervention (PCI) were randomly assigned receive (n=23) or...
Axillary vein puncture (AVP) and cephalic surgical cutdown are recommended in international guidelines because of their low risk pneumothorax chronic lead complications. Directly visualizing puncturing the axillary under ultrasound guidance reduces radiation exposure, provides direct needle visualization, lowers periprocedural Our hypothesis is that ultrasound-guided access safer more feasible than standard fluoroscopic technique. The purpose this study was to assess efficacy safety venous...
The story of heart failure (HF) traces a path from the oldest records human healing practices several millennia ago, winding through various changing models physiology, sickness and health. It passes today's landscape neurohormonal modulation, device therapy, assist devices, towards future therapies, some in development today, as-yet unimagined, based on pathophysiological insights yet to come. This review attempts follow notes left by earlier travellers, as well therapeutic improvements...
Arrhythmogenic cardiomyopathy (ACM) is an inherited heart disease characterized by fibrofatty replacement of the ventricular myocardium, with estimated prevalence 1:5000 people in general population. Sudden cardiac death first manifestation this 16–23% patients ACM. Fibrofatty infiltration can be identified noninvasive magnetic resonance. Studies epicardial fat deposits have suggested pathogenic roles fats mediating diseases and arrhythmias. Although myocardial has been well described ACM,...
We present the case of a 46-year-old man with history complex ventricular arrhythmias preceding development asymptomatic mild left dysfunction, who presented acute-onset heart failure and was ultimately diagnosed dilated cardiomyopathy. Genetic testing identified novel, likely pathogenic mutation in exon 4 BAG3 gene (NM_004281, c.1128del, (p.(Ser377AlafsTer47)), not previously reported literature. Given presence multiple clinical features indicative poor prognosis, he underwent prophylactic...
Abstract Background Glucagon–like peptide–1 receptor agonists (GLP–1 RAs) have been shown to reduce the risk of major cardiovascular events and death in patients with type 2 diabetes mellitus (T2DM). Recent studies suggest a potential antiarrhythmic effect associated GLP–1 activation. However, impact this drug class on prevention complete atrioventricular block (AVB) has not thoroughly investigated. Objective This study aimed evaluate protective RAs AVB T2DM. Methods Following Preferred...
Abstract Background The optimal timing for catheter ablation (CA) in patients with atrial fibrillation (AF) remains uncertain. Objective This study aims to evaluate whether early (within 1 year of diagnosis) compared delayed (≥1 year) is associated a lower rate arrhythmia recurrence. Methods Following the Preferred Reporting Items Systematic Reviews and Meta–Analyses guidelines, we searched Medline, Embase, Scopus identify all observational studies published up October 2024 that risk AF...
Abstract Background Recent studies have suggested a potential antiarrhythmic role for Sodium–Glucose Cotransporter–2 Inhibitors (SGLT2i) in patients with atrial tachyarrhythmias. However, their effects on reducing the recurrence of fibrillation (AF) following catheter ablation (CA) not been thoroughly investigated. Objective This study aimed to determine whether SGLT2i can reduce risk AF after CA. Methods Following Preferred Reporting Items Systematic Reviews and Meta–Analyses guidelines, we...
OPN and Gal‐3 Predict VT/VF in Heart Failure Patients Background Myocardial extracellular matrix remodelling provides electrical heterogeneity entailing ventricular tachycardia/fibrillation (VT/VF) heart failure (HF) patients. Osteopontin (OPN) Galectin‐3 (Gal‐3) are fibrosis markers may reflect the extension of arrhythmogenic substrate. We assessed whether plasma predict risk sustained a cohort HF patients with implantable cardioverter‐defibrillator (ICD). Methods A total 75 underwent...
Abstract Aims Update data regarding the atrial fibrillation (AF)-related mortality trend in Europe remain scant. We assess age- and sex-specific trends AF-related European states between years 2008 2019. Methods results Data on cause-specific deaths population numbers by sex for countries were retrieved through publicly available World Health Organization dataset 2008–2019. Atrial fibrillation-related ascertained when International Classification of Diseases, 10th Revision code I48 was...